全癌症分析表明,BCAP31是多种癌症类型的潜在预后和免疫治疗生物标志物
Yangyong Sun1, Zhi Li2, Jianchao Liu1
1Department of Cardiothoracic Surgery, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu, China.
Frontiers in immunology
|December 31, 2024
概括
B细胞受体关联蛋白31 (BCAP31) 在许多癌症中过度表达,并与预后不佳有关. 准BCAP31可能为癌症治疗提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症基因组学 癌症基因组学
背景情况:
- B细胞受体关联蛋白31 (BCAP31) 是一种涉及癌症发展的跨膜蛋白.
- 它在各种癌症类型中的精确作用需要进一步阐明.
研究的目的:
- 研究BCAP31在癌症发展和进展中的作用.
- 探索BCAP31作为一种潜在的预后和免疫治疗生物标志物.
主要方法:
- 在癌症基因组图谱 (TCGA) 和CCLE数据库中分析BCAP31表达.
- 考克斯回归,复制数变化 (CNV) 分析和免疫透评估 (TIMER2,免疫细胞AI,估计).
- 功能测试包括siRNA淘汰,MTT,殖民地形成,Transwell和伤口愈合测试.
主要成果:
- 在多种癌症中,BCAP31的过度表达与不良预后 (OS,DFI,DSS,PFI) 有关.
- BCAP31的表达与CNV,瘤微环境 (TME) 调制和药物敏感性有关.
- 击败BCAP31抑制了癌细胞的迁移,入侵和增殖.
结论:
- BCAP31作为一种潜在的预后生物标志物,与癌症免疫学有关.
- 研究结果表明BCAP31是新型癌症治疗策略的目标.
更多相关视频
07:41Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
8.8K
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
1.3K
相关概念视频
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...